- Home
- MRVI vs RLGT Comparison
MRVI vs RLGT Comparison
Compare MRVI & RLGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- RLGT
- Stock Information
- Founded
- MRVI 2014
- RLGT 2001
- Country
- MRVI United States
- RLGT United States
- Employees
- MRVI N/A
- RLGT N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- RLGT Oil Refining/Marketing
- Sector
- MRVI Health Care
- RLGT Consumer Discretionary
- Exchange
- MRVI Nasdaq
- RLGT Nasdaq
- Market Cap
- MRVI 262.9M
- RLGT 295.7M
- IPO Year
- MRVI 2020
- RLGT N/A
- Fundamental
- Price
- MRVI $1.98
- RLGT $6.01
- Analyst Decision
- MRVI Hold
- RLGT
- Analyst Count
- MRVI 9
- RLGT 0
- Target Price
- MRVI $6.54
- RLGT N/A
- AVG Volume (30 Days)
- MRVI 1.6M
- RLGT 106.5K
- Earning Date
- MRVI 05-12-2025
- RLGT 05-12-2025
- Dividend Yield
- MRVI N/A
- RLGT N/A
- EPS Growth
- MRVI N/A
- RLGT 32.26
- EPS
- MRVI N/A
- RLGT 0.29
- Revenue
- MRVI $259,185,000.00
- RLGT $858,699,000.00
- Revenue This Year
- MRVI N/A
- RLGT $12.86
- Revenue Next Year
- MRVI $14.23
- RLGT $5.26
- P/E Ratio
- MRVI N/A
- RLGT $20.71
- Revenue Growth
- MRVI N/A
- RLGT N/A
- 52 Week Low
- MRVI $1.67
- RLGT $4.83
- 52 Week High
- MRVI $11.56
- RLGT $7.94
- Technical
- Relative Strength Index (RSI)
- MRVI 43.17
- RLGT 51.15
- Support Level
- MRVI $1.96
- RLGT $5.85
- Resistance Level
- MRVI $2.16
- RLGT $6.13
- Average True Range (ATR)
- MRVI 0.13
- RLGT 0.18
- MACD
- MRVI 0.04
- RLGT 0.04
- Stochastic Oscillator
- MRVI 47.67
- RLGT 68.18
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.